Cite

HARVARD Citation

    Grippin, A. et al. (n.d.). IMMU-41. VERSATILE MRNA-NANOPARTICLE PLATFORM TO REPROGRAM THE BRAIN TUMOR MICROENVIRONMENT AND PREDICT TREATMENT OUTCOME. Neuro-oncology. p. vii140. [Online]. 
  
Back to record